Ophthalmic Equipment Market by Product (Spectacles, Contact Lenses, OCT Scanner, Fundus Camera, Ultrasound, Perimeter, Autorefracter, Slit Lamp, Keratometer, Tonometer, Ophthalmoscope, IOL, OVDs), End User (Consumer, Hospitals) & Region - Global Forecast to 2027
The global ophthalmic equipment market boasts a total value of $63.4 billion in 2022 and is projected to register a growth rate of 5.0% to reach a value of $80.9 billion by 2027. Growth in this market is majorly driven by the high incidence of eye disorders, such as diabetic retinopathy, cataracts, and age-related macular degeneration (AMD), increase in elderly population, and rise in adoption of digital devices.
Global Ophthalmic Equipment Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Ophthalmic Equipment Market Dynamics
Drivers: Increase in elderly population
Over the years, there has been a significant increase in the geriatric population and, subsequently, the prevalence of age-related disorders, including several eye disorders. This is a key factor driving the demand for ophthalmology devices. The tear layer loses stability and degrades faster in the elderly; consequently, the risk of getting severe eye disorders increases significantly with age, particularly after 60 years.
Elderly people suffers from some form of eye disease and is at risk of severe eye problems such as age-related macular degeneration, cataracts, low vision, glaucoma, and diabetic eye disease.
Restraints: High cost and risk associated with eye surgery
Modern eye surgeries are safe but there are some risks associated with surgeries. Some problems can be developed if a patient has a pre-existing visual disorder or other health concerns that might complicate the recovery of the patient. However, risk and complications that result in a loss of vision are rare, certain side effects, like particularly dry eyes and temporary visual disturbances, are present.
LASIKsurgery causes a temporary decrease in tear production, which results in dry eyes and if it's severe than there is another procedure for this. Post-surgery there might be glare, halos, and double vision and LASIK surgery can also cause Astigmatism caused by uneven tissue removal. Eye surgeries using LASIK are costly also. The prices vary depending on the region, the hospital and the type of surgery opted. LASIK costs for both eyes are between USD 2,000- 2,500 in India.LASIK eye surgery costs around USD 1,500-3,000 per eye in US and in UK it costs around USD 1,280-3,800 per eye. Due to this high cost, a smaller number of people opt for such surgeries, and which is expected to restrict the growth of ophthalmic equipment market.
Opportunities: Potential growth opportunities in emerging markets
Emerging markets such as India, Brazil, and Mexico are expected to offer significant growth opportunities for players operating in the globlal ophthalmic equipment market. This can majorly be attributed to the rising incidence of eye diseases in these countries. Developing countries across the globe, are expected to offer potential growth opportunities for players operating in the global market.
Factors such as the improving healthcare infrastructure, increasing healthcare expenditure, rising medical tourism, and increasing government investments are also expected to drive the growth of the market in developing countries across the Asia Pacific and Latin America. Many patients are traveling to India for eye treatments as a result of the high-quality, lower cost treatments offered in the country.
Challenges: Lack of skilled professionals
Although the demand for ophthalmologists has increased significantly—proportional to the growth in population, globally—their number has not. This
is particularly evident in developing countries with a very low number of specialists.
Besides, awareness about eye diseases is quite low among the rural populations of developing countries such as India, Saudi Arabia, Israel, Kenya, and South Africa. Rural healthcare is marked by insufficient infrastructure, a lack of awareness, and poor access to eye care professionals.
The vision care products segment accounted for the largest share of the market, based on product
Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of vision care products segment is attributed to technological advancements in lens materials and eye care devices, rise in adoption of digital devices, increasing prevalence of vision disorders like cataract, glaucoma, obesity and diabetes, and age-related macular degeneration, increase in elderly population, and growing awareness about eyesight correction.
“Consumers segment hold the largest share of the ophthalmic equipment market, by end user”
Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing prevalence of ocular disorders among the geriatric population, the growing adoption of contact lenses for correcting multiple vision dysfunctions such as myopia, astigmatism, presbyopia, and hyperopia, increasing focus on aesthetic look and popularity of colored contact lenses in the fashion industry.
North America accounted for the largest share of the ophthalmic equipment market
In 2021, North America accounted for the largest share the ophthalmic equipment market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America can be attributed to the rising geriatric population, increasing prevalence of ocular disorders, and growing healthcare expenditure.
North America: Ophthalmic Equipment Market Snapshot
To know about the assumptions considered for the study, download the pdf brochure
Ophthalmic Equipment Key Market Players
Major players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc. (US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).
Ophthalmic Equipment Market Scope
|
Report Metric |
Details |
|
Market size available for years |
2020–2027 |
|
Base year considered |
2021 |
|
Forecast period |
2022–2027 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, and End User |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa |
|
Companies covered |
Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India). |
The study categorizes the ophthalmic equipment market based on product, end user, and regional and global level.
By Product
-
Vision Care Products
- Spectacles
-
Contact lenses
- Soft contact lenses
- Rigid gas permeable lenses
- Hybrid contact lenses
-
Surgical devices
-
Cataract surgical devices
- Intraocular lenses
- Ophthalmic Viscoelastic devices
- Phacoemulsification devices
- Cataract surgical lasers
- IOL Injectors
-
Cataract surgical devices
-
Vitreoretinal surgical devices
- Vitrectomy machines
- Vitreoretinal packs
- Photocoagulation lasers
- Illumination devices
- Vitrectomy probes
-
Refractive surgical devices
- Femtosecond lasers
- Excimer lasers
- Other refractive surgical lasers
-
Glaucoma surgical devices
- Glaucoma drainage devices
- Microinvasive glaucoma surgery devices
- Glaucoma laser systems
- Ophthalmic microscopes
-
Ophthalmic surgical accessories
- Surgical instruments & kits
- Ophthalmic forceps
- Ophthalmic spatulas
- Ophthalmic tips & handles
- Ophthalmic scissors
- Macular lenses
- Ophthalmic cannulas
- Other ophthalmic surgical accessories
-
Diagnostic and monitoring devices
- Optical Coherence Tomography Scanners
- Fundus Cameras
- Perimeters/Visual Field Analyzers
- Autorefractors & Keratometers
-
Ophthalmic Ultrasound Imaging Systems
- A-scan ultrasound imaging systems
- B-scan ultrasound imaging systems
- Ultrasound microscopes
- Pachymeters
- Tonometers
- Slit Lamps
- Phoropters
- Wavefront Abberometers
- Optical Biometry Systems
- Ophthalmoscopes
- Lensmeters
- Corneal Topography Systems
- Chart Projectors
- Specular Microscopes
- Retinoscopes
By End User
- Consumers
- Hospitals
- Specialty Clinics & Ambulatory Surgery Centers
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the business and relationships with existing customers and allowing Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets.
- In 2020, Hoya Corporation formed joint venture with GeMax, a distributor partner. GeMax is a specialty promotion service provider of IOLs with a strong market position and a professional reputation in China, The joint venture is named as HOYA GeMax Medical (China).
- In 2020, Bausch Health Companies Inc. announced the spin-off of its leading eye health business into an independent publicly traded entity ("Bausch + Lomb - NewCo") from the remainder of Bausch Health ("BHC"). It will consist of Bausch Health's global vision care, surgical, consumer and ophthalmic Rx businesses.
Frequently Asked Questions (FAQs):
What is the size of Ophthalmic Equipment Market?
The global ophthalmic equipment market is projected to reach USD 80.9 billion by 2027 from USD 63.4 billion in 2022, at a CAGR of 5.0%.
What are the major growth factors of Ophthalmic Equipment Market?
Growth in this market is majorly driven by the high incidence of eye disorders, such as diabetic retinopathy, cataracts, and age-related macular degeneration (AMD), increase in elderly population, and rise in adoption of digital devices.
Who all are the prominent players of Ophthalmic Equipment Market?
Major players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc. (US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 50)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 OPHTHALMIC EQUIPMENT MARKET SEGMENTATION
1.3.2 MARKETS COVERED – BY REGION
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 56)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 7 BOTTOM-UP APPROACH: VISION CARE PRODUCTS COMPANY REVENUE ESTIMATION APPROACH
FIGURE 8 BOTTOM-UP APPROACH: OPHTHALMIC SURGICAL EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH
FIGURE 9 BOTTOM-UP APPROACH: OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH
2.2.1 CAGR PROJECTIONS
FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ON MARKET GROWTH AND CAGR
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: GLOBAL MARKET
3 EXECUTIVE SUMMARY (Page No. - 71)
FIGURE 13 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 14 GLOBAL MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2022 VS. 2027(USD MILLION)
FIGURE 15 GLBOAL MARKET FOR SURGICAL DEVICES, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 GLOBAL MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 19 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 79)
4.1 OPHTHALMIC EQUIPMENT MARKET OVERVIEW
FIGURE 21 INCREASING EYE DISORDERS AND RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
4.2 NORTH AMERICA: MARKET, BY COUNTRY AND END USER (2021)
FIGURE 22 CONSUMERS TO DOMINATE NORTH AMERICAN MARKET IN 2021
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2022 TO 2027
4.4 GLOBAL MARKET, BY REGION (2020–2027)
FIGURE 24 NORTH AMERICA TO DOMINATE MARKET UNTIL 2027
4.5 GLBOAL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 83)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing geriatric population
TABLE 3 INCREASE IN GERIATRIC POPULATION, 2000–2050
5.2.1.2 Rising prevalence of eye disorders
TABLE 4 GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2021 (IN MILLION)
5.2.1.2.1 Cataracts
TABLE 5 NUMBER OF CATARACT SURGERIES, BY COUNTRY (2020 VS 2021)
5.2.1.2.2 Glaucoma
TABLE 6 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS 2040 (IN MILLION)
5.2.1.2.3 Obesity and diabetes
TABLE 7 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS 2045 (MILLION)
5.2.1.2.4 Age-related macular degeneration (AMD)
TABLE 8 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS 2050 (MILLION)
5.2.1.3 Technological advancements in ophthalmic devices
TABLE 9 RECENT PRODUCT LAUNCHES IN GLOBAL MARKET (2019–2021)
5.2.1.4 Increased government initiatives to control visual impairment
5.2.1.5 Rising adoption of contact lenses and spectacles
TABLE 10 PREVALENCE AND PATIENT POPULATION FOR MYOPIA, 2020–2050
5.2.2 RESTRAINTS
5.2.2.1 High cost and risk associated with eye surgeries
5.2.2.2 Increased cost of ophthalmology devices
TABLE 11 PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2021)
5.2.2.3 Rising adoption of refurbished ophthalmic devices
5.2.3 OPPORTUNITIES
5.2.3.1 Potential growth opportunities in emerging markets
5.2.3.2 Low adoption of phacoemulsification devices and premium IOLs in emerging regions
5.2.4 CHALLENGES
5.2.4.1 Low accessibility to eye care in low-income countries
5.2.4.2 Lack of skilled professionals
6 INDUSTRY INSIGHTS (Page No. - 96)
6.1 INDUSTRY TRENDS
6.1.1 INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY
6.1.2 TECHNOLOGICAL ADVANCEMENT IN INTRAOCULAR LENSES
6.1.3 MINIMALLY INVASIVE GLAUCOMA SURGERY
6.2 PRICING ANALYSIS
TABLE 12 REGIONAL PRICING ANALYSIS OF OPHTHALMIC EQUIPMENT, 2021 (USD)
6.2.1 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYERS
TABLE 13 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD)
6.2.2 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYERS
TABLE 14 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD)
6.2.3 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS
TABLE 15 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD)
6.3 PATENT ANALYSIS
6.3.1 PATENT PUBLICATION TRENDS FOR OPHTHALMIC EQUIPMENT
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011– AUGUST 2022)
6.3.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR OPHTHALMIC EQUIPMENT PATENTS (JANUARY 2011–AUGUST 2022)
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR OPHTHALMIC EQUIPMENT (JANUARY 2011–AUGUST 2022)
TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS IN OPHTHALMIC EQUIPMENT MARKET, 2021–2022
6.4 VALUE CHAIN ANALYSIS
FIGURE 30 GLOBAL MARKET: VALUE CHAIN ANALYSIS
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 31 GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
6.6 ECOSYSTEM ANALYSIS
TABLE 17 OPHTHALMIC EQUIPMENTS MARKET: ECOSYSTEM MAPPING
TABLE 18 OPHTHALMIC EQUIPMENTS MARKET: ROLE IN ECOSYSTEM
6.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 19 OPHTHALMIC EQUIPMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7.1 THREAT OF NEW ENTRANTS
6.7.2 THREAT OF SUBSTITUTES
6.7.3 BARGAINING POWER OF BUYERS
6.7.4 BARGAINING POWER OF SUPPLIERS
6.7.5 DEGREE OF COMPETITION
6.8 REGULATORY ANALYSIS
6.8.1 NORTH AMERICA
6.8.1.1 US
6.8.1.2 Canada
6.8.2 EUROPE
6.8.3 ASIA PACIFIC
6.8.3.1 China
6.8.3.2 Japan
6.8.3.3 India
6.8.4 LATIN AMERICA
6.8.4.1 Brazil
6.8.4.2 Mexico
6.8.5 MIDDLE EAST
6.8.6 AFRICA
6.9 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
6.10.1 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGICAL ADVANCED OPHTHALMIC EQUIPMENT DUE TO COVID-19 PANDEMIC
FIGURE 32 REVENUE SHIFT IN OPHTHALMIC EQUIPMENT MARKET
6.11 TRADE ANALYSIS
6.11.1 TRADE ANALYSIS FOR OPHTHALMIC EQUIPMENT PRODUCTS
TABLE 24 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC EQUIPMENT PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 25 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC EQUIPMENT PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION)
6.12 KEY CONFERENCES AND EVENTS IN 2022−2023
TABLE 26 OPHTHALMIC EQUIPMENTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS
TABLE 27 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS
6.13.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS
TABLE 28 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS
6.14 CASE STUDY
7 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT (Page No. - 122)
7.1 INTRODUCTION
TABLE 29 OPHTHALMIC EQUIPMENTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
7.2 VISION CARE PRODUCTS
TABLE 30 VISION CARE PRODUCTS OFFERED BY KEY PLAYERS
TABLE 31 OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 32 OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 SPECTACLES
7.2.1.1 Rising adoption of digital devices to drive market
TABLE 33 SPECTACLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 CONTACT LENSES
TABLE 34 CONTACT LENSES OFFERED BY KEY PLAYERS
TABLE 35 CONTACT LENSES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.1 Soft contact lenses
7.2.2.1.1 Increasing prevalence of myopia to propel adoption
TABLE 37 SOFT CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.2 RGP lenses
7.2.2.2.1 Increased usage of lenses to correct irregularly shaped corneas to drive demand
TABLE 38 RIGID GAS PERMEABLE LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.3 Hybrid Contact Lenses
7.2.2.3.1 Hybrid lenses to provide advantages over soft and rigid lenses
TABLE 39 HYBRID CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SURGICAL DEVICES
TABLE 40 OPHTHALMIC EQUIPMENTS MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 CATARACT SURGICAL DEVICES
TABLE 42 CATARACT SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 43 CATARACT SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.1 Intraocular lenses
7.3.1.1.1 Rising prevalence of cataracts globally to propel segment
TABLE 44 INTRAOCULAR LENSES OFFERED BY KEY PLAYERS
TABLE 45 INTRAOCULAR LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.2 Ophthalmic viscoelastic devices
7.3.1.2.1 Increasing cataract surgeries to support market
TABLE 46 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.3 Phacoemulsification devices
7.3.1.3.1 Advancements in phacoemulsification devices to increase demand
TABLE 47 PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.4 Cataract surgical lasers
7.3.1.4.1 Accuracy and safety of femtosecond laser technology to drive demand
TABLE 48 CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.5 IOL injectors
7.3.1.5.1 Rising need for accurate implantation to boost market
TABLE 49 IOL INJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 IOL INJECTORS OFFERED BY KEY PLAYERS
7.3.2 VITREORETINAL SURGICAL DEVICES
TABLE 51 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2.1 Vitrectomy machines
7.3.2.1.1 Vitrectomy machines to correct retinal errors
TABLE 53 VITRECTOMY MACHINES OFFERED BY KEY PLAYERS
TABLE 54 VITRECTOMY MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2.2 Vitreoretinal packs
7.3.2.2.1 Increasing awareness about vitreoretinal surgery to drive demand
TABLE 55 VITREORETINAL PACKS OFFERED BY KEY PLAYERS
TABLE 56 VITREORETINAL PACKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2.3 Photocoagulation lasers
7.3.2.3.1 Rising prevalence of various eye diseases to drive market
TABLE 57 PHOTOCOAGULATION LASERS OFFERED BY KEY PLAYERS
TABLE 58 PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2.4 Illumination devices
7.3.2.4.1 Portability and power to increase efficiency
TABLE 59 ILLUMINATION DEVICES OFFERED BY KEY PLAYERS
TABLE 60 ILLUMINATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2.5 Vitrectomy probes
7.3.2.5.1 Advancements to rapidly cut speed to remove vitreous bodies
TABLE 61 VITRECTOMY PROBES OFFERED BY KEY PLAYERS
TABLE 62 VITRECTOMY PROBES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 REFRACTIVE SURGICAL DEVICES
TABLE 63 REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3.1 Femtosecond lasers
7.3.3.1.1 Preference for femtosecond lasers over microkeratomes to support market
TABLE 65 FEMTOSECOND LASERS OFFERED BY KEY PLAYERS
TABLE 66 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3.2 Excimer lasers
7.3.3.2.1 Increased occurrence of myopia to drive market
TABLE 67 EXCIMER LASERS OFFERED BY KEY PLAYERS
TABLE 68 EXCIMER LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3.3 Other refractive surgical lasers
TABLE 69 OTHER REFRACTIVE SURGICAL LASERS OFFERED BY KEY PLAYERS
TABLE 70 OTHER REFRACTIVE SURGICAL LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.4 GLAUCOMA SURGICAL DEVICES
TABLE 71 GLAUCOMA SURGICAL DEVICES OFFERED BY KEY PLAYERS
TABLE 72 GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.4.1 Microinvasive glaucoma surgery devices
7.3.4.1.1 Rising preference for microinvasive glaucoma surgery to drive adoption
TABLE 74 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.4.2 Glaucoma drainage devices
7.3.4.2.1 Rising prevalence of glaucoma globally to propel market
TABLE 75 GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.4.3 Glaucoma laser systems
7.3.4.3.1 Increasing prevalence of open-angle glaucoma to drive market
TABLE 76 GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.5 OPHTHALMIC MICROSCOPES
7.3.5.1 Rising occurrence of eye diseases to boost segment
TABLE 77 OPHTHALMIC MICROSCOPES OFFERED BY KEY PLAYERS
TABLE 78 OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6 OPHTHALMIC SURGICAL ACCESSORIES
TABLE 79 OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY PLAYERS
TABLE 80 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.1 Surgical sets & instruments
7.3.6.1.1 Surgical sets & instruments to dominate market
TABLE 82 SURGICAL SETS & INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.2 Ophthalmic tips & handles
7.3.6.2.1 Wide range of tips and handles to drive demand
TABLE 83 OPHTHALMIC TIPS& HANDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.3 Ophthalmic scissors
7.3.6.3.1 Titanium scissors to dominate segment
TABLE 84 OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.4 Ophthalmic forceps
7.3.6.4.1 Forceps to be mostly used in ophthalmological surgeries
TABLE 85 OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.5 Ophthalmic spatulas
7.3.6.5.1 China to be fastest-growing market for ophthalmic spatulas
TABLE 86 OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.6 Macular lenses
7.3.6.6.1 Increased adoption of macular lenses to drive segment
TABLE 87 MACULAR LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.7 Ophthalmic cannulas
7.3.6.7.1 Rising adoption of single-use cannulas to drive market
TABLE 88 OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.6.8 Other ophthalmic surgical accessories
TABLE 89 OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 DIAGNOSTIC & MONITORING DEVICES
TABLE 90 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.1 OPTICAL COHERENCE TOMOGRAPHY SCANNERS
7.4.1.1 OCT scanners to provide high-depth image analysis on real-time basis
TABLE 92 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 93 OCT SCANNERS OFFERED BY KEY MARKET PLAYERS
7.4.2 FUNDUS CAMERAS
7.4.2.1 Rising age-related disorders to drive market
TABLE 94 FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS
TABLE 95 FUNDUS CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.3 PERIMETERS/VISUAL FIELD ANALYZERS
7.4.3.1 Increasing incidence of glaucoma and AMD to propel demand
TABLE 96 PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS
TABLE 97 PERIMETERS/ VISUAL FIELD ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.4 AUTOREFRACTORS & KERATOMETERS
7.4.4.1 Rising visually impaired patients to drive market
TABLE 98 AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS
TABLE 99 AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.5 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
TABLE 100 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.5.1 A-scan ultrasound imaging systems
7.4.5.1.1 Increased usage in cataract surgeries to propel market
TABLE 102 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 103 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.5.2 B-scan ultrasound imaging systems
7.4.5.2.1 Assessment of eyes and orbits to detect eye disorders to drive market
TABLE 104 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 105 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.5.3 Opthalmic UBM Ultrasound
7.4.5.3.1 Rising volume of refractive surgeries globally to drive market
TABLE 106 OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 107 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.5.4 Ophthalmic Pachymeters
7.4.5.4.1 Ophthalmic pachymeters to monitor cornea
TABLE 108 OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS
TABLE 109 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.6 TONOMETERS
7.4.6.1 Rising prevalence of glaucoma to drive demand
TABLE 110 TONOMETERS OFFERED BY KEY MARKET PLAYERS
TABLE 111 TONOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.7 SLIT LAMPS
7.4.7.1 Rising prevalence of ocular conditions to drive market
TABLE 112 SLIT LAMPS OFFERED BY KEY MARKET PLAYERS
TABLE 113 SLIT LAMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.8 PHOROPTERS
7.4.8.1 Phoropters to measure refractive errors
TABLE 114 PHOROPTERS OFFERED BY KEY MARKET PLAYERS
TABLE 115 PHOROPTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.9 WAVEFRONT ABERROMETERS
7.4.9.1 Aberrometers to measure refractive aberrations
TABLE 116 WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS
TABLE 117 WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.10 OPTICAL BIOMETRY SYSTEMS
7.4.10.1 Advantages of optical biometry systems to boost diagnostics
TABLE 118 OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 119 OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.11 OPHTHALMOSCOPES
7.4.11.1 Increasing patients with glaucoma, diabetic retinopathy, and AMD to drive market
TABLE 120 OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 121 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.12 LENSMETERS
7.4.12.1 Rising prevalence of myopia and hyperopia with increasing adoption of glassware to drive market
TABLE 122 LENSMETERS OFFERED BY KEY MARKET PLAYERS
TABLE 123 LENSMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.13 CORNEAL TOPOGRAPHY SYSTEMS
7.4.13.1 Rising LASIK procedures to propel demand
TABLE 124 CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 125 CORNEAL TOPOGRAPHY SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.14 CHART PROJECTORS
7.4.14.1 Eye chart projectors to access different chart types in one device
TABLE 126 CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS
TABLE 127 CHART PROJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.15 SPECULAR MICROSCOPES
7.4.15.1 Increasing diabetic patients to drive market
TABLE 128 SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 129 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.16 RETINOSCOPES
7.4.16.1 Rising prevalence of myopia globally to boost market
TABLE 130 RETINOSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 131 RETINOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 OPHTHALMIC EQUIPMENT MARKET, BY END USER (Page No. - 218)
8.1 INTRODUCTION
TABLE 132 OPHTHALMIC EQUIPMENTS MARKET BY END USER, 2020–2027 (USD MILLION)
8.2 CONSUMERS
8.2.1 INCREASING OCULAR DISORDERS WITH RISING ADOPTION OF CONTACT LENSES AND SPECTACLES TO DRIVE MARKET
TABLE 133 OPHTHALMIC EQUIPMENTS MARKET FOR CONSUMERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HOSPITALS
8.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER FOR ADVANCED INSTRUMENTS TO PROPEL MARKET
FIGURE 35 NUMBER OF HOSPITALS, BY COUNTRY (2019)
TABLE 134 OPHTHALMIC EQUIPMENTS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 SPECIALITY CLINICS AND AMBULATORY SURGERY CENTERS
8.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE TO DRIVE MARKET
FIGURE 36 US: NUMBER OF AMBULATORY SURGICAL CENTERS (2012-2022)
TABLE 135 OPHTHALMIC EQUIPMENTS MARKET FOR SPECIALITY CLINICS AND AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 136 OPHTHALMIC EQUIPMENTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 OPHTHALMIC EQUIPMENT MARKET, BY REGION (Page No. - 226)
9.1 INTRODUCTION
FIGURE 37 OPHTHALMIC EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 137 OPHTHALMIC EQUIPMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT
TABLE 138 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 139 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 140 NORTH AMERICA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 NORTH AMERICA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 NORTH AMERICA: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 NORTH AMERICA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Rising geriatric population and increasing healthcare expenditure to drive market
TABLE 149 US: KEY MACROINDICATORS
TABLE 150 OCULAR CONDITIONS IN US: 2000–2020 (MILLION)
TABLE 151 US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 152 US: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 US: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 US: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 US: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 US: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising awareness about eye care and increasing ocular diseases to drive market
TABLE 161 CANADA: KEY MACROINDICATORS
TABLE 162 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 163 CANADA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 CANADA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 CANADA: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 CANADA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 172 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 173 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 174 EUROPE: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 EUROPE: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 EUROPE: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 EUROPE: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing healthcare expenditure to boost market
TABLE 183 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 184 GERMANY: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 GERMANY: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 GERMANY: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 GERMANY: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising prevalence of diabetes-related eye diseases to drive market
TABLE 193 UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 194 UK: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 UK: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 UK: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 UK: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 UK: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Growing eye surgeries to drive demand
TABLE 203 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 204 FRANCE: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 FRANCE: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 FRANCE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 FRANCE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 208 FRANCE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 FRANCE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 FRANCE: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 FRANCE: OPHTHALMIC EQUIPMENTS MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing healthcare spending and growing geriatric population to propel market
TABLE 213 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 214 ITALY: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 ITALY: OPHTHALMIC EQUIPMENTS MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 ITALY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 217 ITALY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 ITALY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 ITALY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 ITALY: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 221 ITALY: OPHTHALMIC EQUIPMENTS MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 222 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing ophthalmic surgical procedures to drive market
TABLE 223 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 224 SPAIN: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 225 SPAIN: OPHTHALMIC EQUIPMENTS MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 SPAIN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 SPAIN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 228 SPAIN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 SPAIN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 230 SPAIN: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 231 SPAIN: OPHTHALMIC EQUIPMENTS MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 232 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 233 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 234 REST OF EUROPE: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 REST OF EUROPE: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 236 REST OF EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 REST OF EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 238 REST OF EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 239 REST OF EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 240 REST OF EUROPE: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 241 REST OF EUROPE: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 242 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 39 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT
TABLE 243 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 244 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 245 ASIA PACIFIC: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 246 ASIA PACIFIC: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 248 ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 249 ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 250 ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 ASIA PACIFIC: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 252 ASIA PACIFIC: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 253 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Rising prevalence of cataracts to drive market
TABLE 254 CHINA: KEY MACROINDICATORS
TABLE 255 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 256 CHINA: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 257 CHINA: OPHTHALMIC EQUIPMENTS MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 258 CHINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 259 CHINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 260 CHINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 261 CHINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 262 CHINA: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 263 CHINA: OPHTHALMIC EQUIPMENTS MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Strong manufacturing capabilities to propel market
TABLE 265 JAPAN: KEY MACROINDICATORS
TABLE 266 JAPAN: OPHTHALMIC EQUIPMENTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 267 JAPAN: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 268 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 269 JAPAN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 270 JAPAN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 271 JAPAN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 272 JAPAN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 273 JAPAN: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 274 JAPAN: OPHTHALMIC EQUIPMENTS MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 275 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increasing geriatric population and prevalence of eye disorders to support market
TABLE 276 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 277 INDIA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 278 INDIA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 279 INDIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 280 INDIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 281 INDIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 282 INDIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 283 INDIA: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 284 INDIA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 285 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Increased cataract surgeries to drive market
TABLE 286 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 287 AUSTRALIA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 288 AUSTRALIA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 AUSTRALIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 AUSTRALIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 AUSTRALIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 292 AUSTRALIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 293 AUSTRALIA: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 294 AUSTRALIA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 295 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Growing focus on medical tourism to boost market
TABLE 296 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 297 SOUTH KOREA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 298 SOUTH KOREA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 299 SOUTH KOREA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 SOUTH KOREA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 SOUTH KOREA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 302 SOUTH KOREA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 SOUTH KOREA: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 304 SOUTH KOREA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 305 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 306 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 307 REST OF ASIA PACIFIC: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 REST OF ASIA PACIFIC: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 REST OF ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 REST OF ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 311 REST OF ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 312 REST OF ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 313 REST OF ASIA PACIFIC: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 314 REST OF ASIA PACIFIC: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 315 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 316 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 317 LATIN AMERICA: OPHTHALMIC EQUIPMENTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 318 LATIN AMERICA: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 319 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 320 LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 321 LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 322 LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 323 LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 324 LATIN AMERICA: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 325 LATIN AMERICA: OPHTHALMIC EQUIPMENTS MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 326 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Government support and initiatives to boost market
TABLE 327 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 328 BRAZIL: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 329 BRAZIL: OPHTHALMIC EQUIPMENTS MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 330 BRAZIL: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 331 BRAZIL: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 332 BRAZIL: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 333 BRAZIL: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 334 BRAZIL: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 335 BRAZIL: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 336 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Growing incidence of eye disorders to drive market
TABLE 337 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 338 MEXICO: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 339 MEXICO: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 340 MEXICO: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 341 MEXICO: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 342 MEXICO: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 343 MEXICO: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 344 MEXICO: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 345 MEXICO: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 346 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 ARGENTINA
9.5.3.1 Increasing healthcare expenditure and well-developed healthcare system to favor market
TABLE 347 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 348 ARGENTINA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 349 ARGENTINA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 350 ARGENTINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 351 ARGENTINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 352 ARGENTINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 353 ARGENTINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 354 ARGENTINA: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 355 ARGENTINA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 356 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 357 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 358 REST OF LATIN AMERICA: MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 359 REST OF LATIN AMERICA: MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 360 REST OF LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 361 REST OF LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 362 REST OF LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 363 REST OF LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 364 REST OF LATIN AMERICA: MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 365 REST OF LATIN AMERICA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 366 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPROVING HEALTHCARE EXPENDITURE TO DRIVE MARKET
TABLE 367 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 368 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENTS MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 369 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENTS MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 370 MIDDLE EAST & AFRICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 371 MIDDLE EAST & AFRICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 372 MIDDLE EAST & AFRICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 373 MIDDLE EAST & AFRICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 374 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENTS MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 375 MIDDLE EAST & AFRICA: MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 376 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 348)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 40 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 41 REVENUE ANALYSIS OF TOP PLAYERS IN OPHTHALMIC EQUIPMENT MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 42 OPHTHALMIC EQUIPMENTS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 377 OPHTHALMIC EQUIPMENT MARKET: DEGREE OF COMPETITION
10.4.1 OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET
FIGURE 43 OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET SHARE, BY KEY PLAYERS (2021)
TABLE 378 OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET: DEGREE OF COMPETITION
10.4.2 CONTACT LENSES MARKET
FIGURE 44 CONTACT LENSES MARKET SHARE, BY KEY PLAYERS (2021)
TABLE 379 CONTACT LENSES MARKET: DEGREE OF COMPETITION
10.4.3 OPHTHALMIC SURGICAL DEVICES MARKET
FIGURE 45 OPHTHALMIC SURGICAL DEVICES MARKET SHARE, BY KEY PLAYERS (2021)
TABLE 380 OPHTHALMIC SURGICAL DEVICES MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 46 OPHTHALMIC EQUIPMENTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UP COMPANIES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 47 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UP COMPANIES (2021)
10.7 COMPANY FOOTPRINT
TABLE 381 COMPANY FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET
10.8 PRODUCT FOOTPRINT OF MAJOR PLAYERS IN GLOBAL MARKET
TABLE 382 PRODUCT FOOTPRINT: GLOBAL MARKET (2021)
10.9 END USER FOOTPRINT OF MAJOR PLAYERS IN GLOBAL MARKET
TABLE 383 END USER FOOTPRINT: GLOBAL MARKET (2021)
10.10 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN GLOBAL MARKET
TABLE 384 GEOGRAPHIC FOOTPRINT: GLOBAL MARKET (2021)
TABLE 385 GLOBAL MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.11 COMPETITIVE SCENARIO
10.11.1 PRODUCT LAUNCHES
TABLE 386 PRODUCT LAUNCHES, JANUARY 2019–APRIL 2022
10.11.2 DEALS
TABLE 387 DEALS, JANUARY 2019–APRIL 2022
10.11.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 370)
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 BAUSCH HEALTH COMPANIES INC.
TABLE 389 BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW
FIGURE 48 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021)
11.1.2 ALCON
TABLE 390 ALCON: COMPANY OVERVIEW
FIGURE 49 ALCON: COMPANY SNAPSHOT (2021)
11.1.3 CARL ZEISS MEDITEC AG
TABLE 391 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW
FIGURE 50 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
11.1.4 JOHNSON & JOHNSON
TABLE 392 JOHNSON & JOHNSON: COMPANY OVERVIEW
FIGURE 51 JOHNSON & JOHNSON VISION CARE: COMPANY SNAPSHOT (2021)
11.1.5 HOYA CORPORATION
FIGURE 52 HOYA CORPORATION: COMPANY SNAPSHOT (2021)
11.1.6 THE COOPER COMPANIES, INC.
TABLE 394 THE COOPER COMPANIES, INC.: COMPANY OVERVIEW
FIGURE 53 THE COOPER COMPANIES, INC. (COOPERVISION): COMPANY SNAPSHOT (2021)
11.1.7 ESSILORLUXOTTICA
TABLE 395 ESSILORLUXOTTICA: COMPANY OVERVIEW
FIGURE 54 ESSILORLUXOTTICA: COMPANY SNAPSHOT (2021)
11.1.8 CANON
TABLE 396 CANON: COMPANY OVERVIEW
FIGURE 55 CANON: COMPANY SNAPSHOT (2021)
11.1.9 GLAUKOS CORPORATION
TABLE 397 GLAUKOS CORPORATION: COMPANY OVERVIEW
FIGURE 56 GLAUKOS CORPORATION: COMPANY SNAPSHOT (2021)
11.1.10 NIDEK CO., LTD.
TABLE 398 NIDEK CO., LTD.: COMPANY OVERVIEW
11.1.11 TOPCON CORPORATION
FIGURE 57 TOPCON CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 399 TOPCON CORPORATION: COMPANY OVERVIEW
11.1.12 ZIEMER OPHTHALMIC SYSTEMS
TABLE 400 ZIEMER OPHTHALMIC SYSTEMS: COMPANY OVERVIEW
11.1.13 STAAR SURGICAL
TABLE 401 STAAR SURGICAL: COMPANY OVERVIEW
FIGURE 58 STAAR SURGICAL: COMPANY SNAPSHOT (2021)
11.1.14 HAAG-STREIT
TABLE 402 HAAG-STREIT: COMPANY OVERVIEW
11.1.15 QUANTEL MEDICAL
TABLE 403 QUANTEL MEDICAL: COMPANY OVERVIEW
11.1.16 COBURN TECHNOLOGIES, INC.
TABLE 404 COBURN TECHNOLOGIES, INC.: COMPANY OVERVIEW
11.1.17 FCI OPHTHALMICS
TABLE 405 FCI OPHTHALMICS: COMPANY OVERVIEW
11.1.18 MATRONIX INDIA CORPORATION
TABLE 406 MATRONIX INDIA CORPORATION: COMPANY OVERVIEW
11.1.19 HEINE OPTOTECHNIK
TABLE 407 HEINE OPTOTECHNIK.: COMPANY OVERVIEW
11.1.20 VISIONIX
TABLE 408 VISIONIX: COMPANY OVERVIEW
11.1.21 NEO VISION
TABLE 409 NEO VISION: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 CLEAR LABS
11.2.2 APPASAMY ASSOCIATES
11.2.3 OPHTEC BV
11.2.4 LUMENIS
11.2.5 INTUVISION LABS
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 448)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ophthalmic equipment market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side and demand side are detailed below. Industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the ophthalmic equipment industry were interviewed to obtain and verify both the qualitative and quantitative aspects of this research study. A robust primary research methodology has been adopted to validate the contents of the report and fill in the gaps.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the revenue share analysis, primary interviews, and top-down approach (assessment of Individual shares of each ophthalmic equipment product, and end user).
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, and forecast the global ophthalmic equipment market based on the product, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall ophthalmic equipment market
- To analyze opportunities in the global ophthalmic equipment market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the global ophthalmic equipment market with respect to five regions—North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile key players in the ophthalmic equipment market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments, such as product launches and approvals, agreements, partnerships, collaborations, acquisitions, joint ventures, spin-off, expansions, and R&D activities of leading players in the global ophthalmic equipment market
- To benchmark players in the market using the “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy within the ophthalmic equipment market
Available Customizations
With the given market data, MarketsandMarkets offers customizations per your company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
- Further breakdown of the Rest of the European ophthalmic equipment market into the Russia, Denmark, Finland, Sweden, Switzerland, the Netherlands, Norway, Poland, Portugal, Romania, Turkey, Austria, and Belgium.
- Further breakdown of the Rest of the Asia Pacific ophthalmic equipment market into Taiwan, New Zealand, Thailand, Singapore, and Malaysia.
- Further breakdown of the Rest of the Latin America ophthalmic equipment market into Chile, Peru, Venezuela, Colombia, Guatemala, Ecuador, Bolivia, Haiti, Cuba, Costa Rica, and Guyana.
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Top 10 companies in ophthalmic surgical instruments Market
top 10 companies in the ophthalmic surgical instruments market, based on their market share and revenue:
These companies are leading players in the ophthalmic surgical instruments market, with a wide range of products and services, including surgical instruments, diagnostic equipment, and vision care products. They have strong brand recognition and significant resources to invest in research and development, marketing, and distribution, which gives them a competitive advantage in the market.
Future ophthalmic instruments market trends
The ophthalmic instruments market is expected to see several trends in the future. Here are some potential trends to watch:
Technological advancements: The ophthalmic instruments market is seeing rapid advancements in technology, including the development of advanced imaging techniques, such as optical coherence tomography (OCT), which can provide detailed images of the eye. Other advances include the development of laser technologies for vision correction and the use of artificial intelligence (AI) and machine learning for image analysis and diagnosis.
Increase in demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures in ophthalmology, which is driving the development of new instruments and techniques. For example, micro-invasive glaucoma surgery (MIGS) is becoming more popular as a treatment for glaucoma, and new instruments are being developed to support these procedures.
Growing demand for telemedicine: Telemedicine is becoming increasingly popular in ophthalmology, particularly for remote consultations and diagnosis. This is due to the availability of high-quality imaging devices and the development of secure online platforms that allow patients to consult with ophthalmologists remotely.
Aging population: The aging population is a significant driver of growth in the ophthalmic instruments market. As the population ages, the prevalence of age-related eye diseases such as cataracts, glaucoma, and macular degeneration is expected to increase, driving demand for ophthalmic instruments and procedures.
Increasing prevalence of myopia: Myopia, or nearsightedness, is becoming increasingly common, particularly among younger people. This is driving demand for instruments and procedures to correct myopia, such as refractive surgery and contact lenses.
Optometry equipment Market Growth Strategy for CEO
As a CEO, there are several key factors that I would consider when developing a growth strategy for the optometry equipment market. Here are some of the key considerations:
Market segmentation: The optometry equipment market is highly segmented, with different instruments and technologies serving different parts of the market. As a CEO, I would analyze the market to identify areas of high growth potential and prioritize investments accordingly.
Technology trends: Technology is advancing rapidly in the optometry equipment market, with new imaging and diagnostic technologies being developed all the time. As a CEO, I would closely monitor these trends and invest in R&D to stay ahead of the competition.
Competitive landscape: The optometry equipment market is highly competitive, with many players vying for market share. As a CEO, I would assess the competitive landscape to identify areas of opportunity and potential threats.
Regulatory environment: The optometry equipment market is subject to regulation, both in terms of product safety and marketing claims. As a CEO, I would ensure that my company is in compliance with all relevant regulations and invest in regulatory affairs to stay up to date on changing regulations.
Recent specific examples of growth strategies in the optometry equipment market include:
Expansion into emerging markets: Many companies in the optometry equipment market are looking to expand into emerging markets such as Asia, Latin America, and Africa. For example, in 2021, EssilorLuxottica announced plans to invest $20 million to expand its optical lens manufacturing capacity in India.
Acquisitions and partnerships: In recent years, there have been several high-profile acquisitions and partnerships in the optometry equipment market. For example, in 2019, Carl Zeiss Meditec acquired IanTech, a UK-based company that develops micro-interventional cataract surgery technology.
Development of new technologies: Many companies in the optometry equipment market are investing heavily in R&D to develop new technologies. For example, in 2021, Topcon Healthcare announced the launch of a new digital microscope system for ophthalmic surgery, which is designed to provide high-quality imaging and video capabilities.
In summary, as a CEO, I would take a comprehensive approach to developing a growth strategy for the optometry equipment market, considering market segmentation, technology trends, the competitive landscape, and the regulatory environment. I would also look to recent examples of successful growth strategies in the market, such as expansion into emerging markets, acquisitions and partnerships, and the development of new technologies.
Future hypothetic growth opportunities in ophthalmic surgical instruments Market
Minimally invasive surgery: There is a growing demand for minimally invasive procedures in ophthalmology, which is driving the development of new instruments and techniques. This trend is likely to continue in the future, and companies that are able to develop instruments that can perform complex procedures with minimal trauma to the eye are likely to see significant growth.
Advanced imaging: Advances in imaging technologies, such as optical coherence tomography (OCT) and adaptive optics, are enabling ophthalmic surgeons to visualize the eye in greater detail than ever before. As these technologies continue to improve, there may be opportunities to develop new surgical instruments that can take advantage of these advances.
Artificial intelligence (AI): AI is increasingly being used in ophthalmology to assist with diagnosis and treatment planning. In the future, there may be opportunities to develop surgical instruments that incorporate AI algorithms to guide surgeons during procedures.
Gene therapy: Gene therapy is a promising area of research in ophthalmology, with several clinical trials underway for the treatment of inherited retinal diseases. As these treatments become more widely available, there may be opportunities to develop new surgical instruments to support these procedures.
Telemedicine: Telemedicine is becoming increasingly popular in ophthalmology, particularly for remote consultations and diagnosis. As this trend continues, there may be opportunities to develop new surgical instruments that can be used in conjunction with telemedicine platforms.
Future hypothetic niche threats for ophthalmic instruments market
Competition from alternative therapies: There is a growing interest in alternative therapies for eye diseases, such as acupuncture and herbal remedies. If these therapies gain wider acceptance, they may represent a threat to the ophthalmic instruments market.
Disruptive technologies: Disruptive technologies, such as nanotechnology and 3D printing, could potentially be used to develop new instruments that are more efficient or cost-effective than traditional instruments. If these technologies gain wider adoption in the ophthalmic industry, they could pose a threat to existing companies.
Changes in healthcare policy: Changes in healthcare policy, such as increased regulation or reimbursement cuts, could impact the profitability of companies in the ophthalmic instruments market.
Economic downturns: Economic downturns can lead to decreased demand for medical equipment, including ophthalmic instruments. A prolonged economic downturn could pose a significant threat to companies in the market.
Cybersecurity threats: As medical devices become more connected, there is a growing risk of cybersecurity threats, such as hacking or data breaches. A significant cybersecurity event could impact the reputation and financial performance of companies in the ophthalmic instruments market.
- Alcon Inc. (a subsidiary of Novartis)
- Johnson & Johnson Vision
- Bausch + Lomb (a subsidiary of Bausch Health Companies Inc.)
- Carl Zeiss Meditec AG
- Hoya Corporation
- NIDEK Co. Ltd.
- Topcon Corporation
- STAAR Surgical Company
- HOYA Surgical Optics
- Lumenis
Generating Response ...
Growth opportunities and latent adjacency in Ophthalmic Equipment Market